(Q39598020)

English

Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.

scientific article published on March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL. (English)

1 reference

Europe PubMed Central

13 September 2017

author name string

Jackson E Fowler

1

1 reference

Europe PubMed Central

13 September 2017

Steven A Bigler

2

1 reference

Europe PubMed Central

13 September 2017

Paul B Farabaugh

3

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

94

1 reference

Europe PubMed Central

13 September 2017

1661-1667

1 reference

Europe PubMed Central

13 September 2017

6

1 reference

Europe PubMed Central

13 September 2017

The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Determination of prostate volume by transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Race and the histologic grade of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Cancer statistics for African Americans, 1996

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10446

21 January 2018

Identifiers

10.1002/CNCR.10446

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39598020&oldid=1473756258"